Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer

Prostate cancer (PCa) is a clinically heterogeneous disease and currently, accurate diagnostic and prognostic molecular biomarkers are lacking. This study aimed to identify novel DNA hypermethylation markers for PCa with future potential for blood-based testing. Accordingly, to search for genes spec...

Descripción completa

Detalles Bibliográficos
Autores principales: Bjerre, Marianne T., Strand, Siri H., Nørgaard, Maibritt, Kristensen, Helle, Rasmussen, Anne KI, Mortensen, Martin Mørck, Fredsøe, Jacob, Mouritzen, Peter, Ulhøi, Benedicte, Ørntoft, Torben, Borre, Michael, Sørensen, Karina D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429171/
https://www.ncbi.nlm.nih.gov/pubmed/30866497
http://dx.doi.org/10.3390/ijms20051173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429171/
https://www.ncbi.nlm.nih.gov/pubmed/30866497
http://dx.doi.org/10.3390/ijms20051173

Ejemplares similares